Cargando…
Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
Checkpoint markers and immune checkpoint inhibitors have been increasingly identified and developed as potential immunotherapeutic targets in various human cancers. Despite valuable efforts to discover novel immune checkpoints and their ligands, the precise roles of their therapeutic functions, as w...
Autores principales: | Kamali, Ali N., Bautista, José M., Eisenhut, Michael, Hamedifar, Haleh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469281/ https://www.ncbi.nlm.nih.gov/pubmed/37662491 http://dx.doi.org/10.1177/25151355231192043 |
Ejemplares similares
-
The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia
por: Williams, Patrick, et al.
Publicado: (2018) -
Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal Cancer
por: Benelli, Roberto, et al.
Publicado: (2023) -
Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
por: Chatterjee, Samit, et al.
Publicado: (2017) -
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
por: Roy, Dia, et al.
Publicado: (2023) -
Medical Biotechnology Trends and Achievements in Iran
por: Mahboudi, Fereidoun, et al.
Publicado: (2012)